News Focus
News Focus
icon url

HyGro

10/18/22 12:41 AM

#522690 RE: X Master #522689

Considering Optune has been approved and achieved 13% survival rate in 5 years similar to what DCVax-L is currently trying to report. UK regulators will see the same benefit, then it is pricing.